Key references: Periprocedural management of adults with type 1 diabetes
- American Diabetes Association. 14. Diabetes care in the hospital: Standards of medical care in diabetes-2018. Diabetes Care 2018;41(Suppl 1):S144–S51. https://www.ncbi.nlm.nih.gov/pubmed/29222385
- Australian Diabetes Society (ADS). Alert update January 2022 - Periprocedural Diabetic Ketoacidosis (DKA) with SGLT2 Inhibitor Use In People with Diabetes. Sydney: ADS; 2022. https://diabetessociety.com.au/position-statements.asp
- Australian Diabetes Society (ADS). Peri-operative diabetes management guidelines. Sydney: ADS; 2012. https://diabetessociety.com.au/position-statements.asp
- Diabetes Canada Clinical Practice Guidelines Expert Committee, Malcolm J, Halperin I, Miller DB, Moore S, Nerenberg KA, et al. In-hospital management of diabetes. Can J Diabetes 2018;42 Suppl 1:S115–S23. https://www.ncbi.nlm.nih.gov/pubmed/29650083
- Joint British Diabetes Societies Inpatient Care Group. The management of adults with diabetes undergoing surgery and elective procedures: Improving standards. London: Diabetes UK; Revised March 2016. https://www.diabetes.org.uk/professionals/position-statements-reports/specialist-care-for-children-and-adults-and-complications/management-of-adults-with-diabetes-undergoing-surgery-and-elective-procedures-improving-standards
- Therapeutic Goods Administration (TGA). Sodium glucose co-transporter 2 inhibitors. Safety advisory - diabetic ketoacidosis and surgical procedures. Canberra: TGA; 2018 Accessed July 2018. https://www.tga.gov.au/alert/sodium-glucose-co-transporter-2-inhibitors